litlas
Log inCreate account

Andrew V. Schally

Active 1955–2025

271
Papers
37,130
Citations
117
h-index
269
i10-index

Citations

Citations per year for Andrew V. Schally1966: 3 citations1967: 2 citations1968: 7 citations1969: 13 citations1970: 26 citations1971: 66 citations1972: 62 citations1973: 75 citations1974: 73 citations1975: 167 citations1976: 165 citations1977: 165 citations1978: 247 citations1979: 173 citations1980: 201 citations1981: 182 citations1982: 181 citations1983: 157 citations1984: 130 citations1985: 125 citations1986: 149 citations1987: 104 citations1988: 88 citations1989: 91 citations1990: 85 citations1991: 82 citations1992: 94 citations1993: 59 citations1994: 107 citations1995: 71 citations1996: 85 citations1997: 99 citations1998: 110 citations1999: 196 citations2000: 207 citations2001: 167 citations2002: 151 citations2003: 241 citations2004: 137 citations2005: 130 citations2006: 102 citations2007: 97 citations2008: 88 citations2009: 108 citations2010: 90 citations2011: 71 citations2012: 94 citations2013: 96 citations2014: 78 citations2015: 91 citations2016: 82 citations2017: 90 citations2018: 90 citations2019: 302 citations2020: 280 citations2021: 371 citations2022: 244 citations2023: 188 citations2024: 448 citations2025: 144 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,208 citing papers, 37.9% of this breakdownUnited Kingdom: 340 citing papers, 5.9% of this breakdownChina: 337 citing papers, 5.8% of this breakdownCanada: 328 citing papers, 5.6% of this breakdownGermany: 291 citing papers, 5% of this breakdownItaly: 225 citing papers, 3.9% of this breakdownFrance: 220 citing papers, 3.8% of this breakdownJapan: 176 citing papers, 3% of this breakdownNetherlands: 170 citing papers, 2.9% of this breakdownSweden: 164 citing papers, 2.8% of this breakdownSwitzerland: 122 citing papers, 2.1% of this breakdownAustralia: 117 citing papers, 2% of this breakdown
0%37.9%Other 19.3%

Institutions

Fields

  • Medicine54%
  • Neuroscience21.7%
  • Biochemistry, Genetics and Molecular Biology15.5%
  • Psychology2%
  • Immunology and Microbiology1.7%
  • Agricultural and Biological Sciences1.1%
  • Other4%

Topics

  • Growth Hormone and Insulin-like Growth Factors5.1%
  • Neuropeptides and Animal Physiology5%
  • Hypothalamic control of reproductive hormones4.6%
  • Stress Responses and Cortisol3.8%
  • Neuroendocrine Tumor Research Advances3.5%
  • Receptor Mechanisms and Signaling3%
  • Other75%

Coauthors

All papers

Open in search
  1. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch

    Authors: Jayantha B. Tennakoon, Yan Shi, Jing Han, Efrosini Tsouko, Mark A. White, Alan R. Burns, Anli Zhang, Xuefeng Xia, Olga Ilkayeva, Xin Li, Michael Ittmann, Ferenc G. Rick, Andrew V. Schally, Daniel E. Frigo - Oncogene 2013 cited by 208

  2. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer

    Authors: Andrew V. Schally, József L. Varga, J. Engel - Nature Clinical Practice Endocrinology &#38 Metabolism 2007 cited by 210

  3. P53, GHRH, inflammation and cancer

    Authors: Nektarios Barabutis, Andrew V. Schally, Agnieszka Siejka - EBioMedicine 2018 cited by 105

  4. Acute promyelocytic leukemia (APL): a review of the literature

    Authors: Joaquín J. Jiménez, Ravinder S. Chale, Andrea C. Abad, Andrew V. Schally - Oncotarget 2020 cited by 124

  5. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes

    Authors: Barbara Ludwig, Stefan Ludwig, Anja Steffen, Yvonne Knauf, Baruch Zimerman, Sophie Heinke, Susann Lehmann, Undine Schubert, Janine Schmid, Martina Bleyer, Uwe Schönmann, Clark K. Colton, Ezio Bonifacio, Michele Solimena, Andreas Reichel, Andrew V. Schally, Avi Rotem, Uriel Barkai, Helena Grinberg-Rashi, Franz‐Josef Kaup, Yuval Avni, Peter M. Jones, Stefan R. Bornstein - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 120

  6. Transplantation of human islets without immunosuppression

    Authors: Barbara Ludwig, Andreas Reichel, Anja Steffen, Baruch Zimerman, Andrew V. Schally, Norman L. Block, Clark K. Colton, Stefan Ludwig, Stephan Kersting, Ezio Bonifacio, Michele Solimena, Zohar Gendler, Avi Rotem, Uriel Barkai, Stefan R. Bornstein - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 273

  7. Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis

    Authors: Alexia Belavgeni, Stefan R. Bornstein, Anne von Mäßenhausen, Wulf Tonnus, Julian Stumpf, Claudia Meyer, Evelyn Othmar, Markus Latk, Waldemar Kanczkowski, Matthias Kroiß, Constanze Hantel, Christian Hugo, Martin Faßnacht, Christian G. Ziegler, Andrew V. Schally, Nils Krone, Andreas Linkermann - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 100

  8. Agonistic analog of growth hormone–releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke

    Authors: Yueyang Liu, Jingyu Yang, Xiaohang Che, Jianhua Huang, Xianyang Zhang, Xiaoxiao Fu, Jialing Cai, Yang Yao, Haotian Zhang, Ruiping Cai, Xiaomin Su, Qian Xu, Fu Ren, Renzhi Cai, Andrew V. Schally, Ming-Sheng Zhou - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 42

  9. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers

    Authors: Zoltán Rékási, Tamás Czömpöly, Andrew V. Schally, Gábor Halmos - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 178

  10. Actions and Potential Therapeutic Applications of Growth Hormone–Releasing Hormone Agonists

    Authors: Andrew V. Schally, Xianyang Zhang, Renzhi Cai, Joshua M. Hare, Riccarda Granata, Manuela Bartoli - Endocrinology 2019 cited by 73

  11. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice

    Authors: Lucia Recinella, Annalisa Chiavaroli, Giustino Orlando, Claudio Ferrante, Guya Diletta Marconi, Iacopo Gesmundo, Riccarda Granata, Renzhi Cai, Wei Sha, Andrew V. Schally, Luigi Brunetti, Sheila Leone - Scientific Reports 2020 cited by 48

  12. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity

    Authors: Renzhi Cai, Xianyang Zhang, Haibo Wang, Tengjiao Cui, Gábor Halmos, Wei Sha, Jinlin He, Petra Popovics, Irving Vidaurre, Chongxu Zhang, Mehdi Mirsaeidi, Andrew V. Schally - Peptides 2021 cited by 27

  13. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells

    Authors: Giuseppina Granato, Iacopo Gesmundo, Francesca Pedrolli, Ramesh Kasarla, Laura Begani, Dana Banfi, Stefania Bruno, Tatiana Lopatina, Maria Felice Brizzi, Renzhi Cai, Wei Sha, Ezio Ghigo, Andrew V. Schally, Riccarda Granata - Frontiers in Immunology 2023 cited by 18

  14. Gonadotropin-Releasing Hormone: One Polypeptide Regulates Secretion of Luteinizing and Follicle-Stimulating Hormones

    Authors: Andrew V. Schally, Akira Arimura, Abba J. Kastin, H. Matsuo, Yukihiro Baba, Tommie W. Redding, R.M.G. Nair, Luciano Debéljuk, W. F. White - Science 1971 cited by 765

  15. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities

    Authors: József L. Varga, Andrew V. Schally, Valér Csernus, Márta Zarándi, Gábor Halmos, Kate Groot, Zoltán Rékási - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 97

  16. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities

    Authors: Renzhi Cai, Andrew V. Schally, Tengjiao Cui, Luca Szalontay, Gábor Halmos, Wei Sha, Magdolna Kovács, Miklós Jászberényi, Jinlin He, Ferenc G. Rick, Petra Popovics, Rosemeire M. Kanashiro‐Takeuchi, Joshua M. Hare, Norman L. Block, Márta Zarándi - Peptides 2013 cited by 84

  17. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target

    Authors: Xiao Xiong, Xiurong Ke, Lu Wang, Zhimeng Yao, Yi Guo, Xianyang Zhang, Yuping Chen, Chi Pui Pang, Andrew V. Schally, Hao Zhang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 46

  18. Agonist of growth hormone–releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury

    Authors: Ling‐Ping Cen, Tsz Kin Ng, Jiajian Liang, Ciyan Xu, Xi Zhuang, Yufen Liu, Shao-Lang Chen, Yanxuan Xu, Qichen Yang, Xiang‐Ling Yuan, Yongjie Qin, Sun On Chan, Haoyu Chen, Mingzhi Zhang, Andrew V. Schally, Chi Pui Pang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2021 cited by 21

  19. Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma

    Authors: Iacopo Gesmundo, Francesca Pedrolli, Nicoletta Vitale, Alessia Bertoldo, Giulia Orlando, Dana Banfi, Giuseppina Granato, Ramesh Kasarla, F. Balzola, Silvia Deaglio, Renzhi Cai, Wei Sha, Mauro Papotti, Ezio Ghigo, Andrew V. Schally, Riccarda Granata - International Journal of Molecular Sciences 2022 cited by 16

  20. Growth hormone-releasing hormone: not only a neurohormone

    Authors: Hippokratis Kiaris, Ioulia Chatzistamou, Athanasios G. Papavassiliou, Andrew V. Schally - Trends in Endocrinology and Metabolism 2011 cited by 99

  21. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling

    Authors: Jinfeng Gan, Xiurong Ke, Jiali Jiang, Hongmei Dong, Zhimeng Yao, Yusheng Lin, Wan‐Wan Lin, Xiao Wu, Shumei Yan, Yi-Xuan Zhuang, Wai Kit Chu, Renzhi Cai, Xianyang Zhang, Herman S. Cheung, Norman L. Block, Chi Pui Pang, Andrew V. Schally, Hao Zhang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 79

  22. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

    Authors: Ferenc G. Rick, Andrew V. Schally, Norman L. Block, Mehrdad Nadji, Károly Szepesházi, Márta Zarándi, Irving Vidaurre, Roberto Pérez‐Castañeda, Gábor Halmos, Luca Szalontay - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 77

  23. Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation

    Authors: Lin Du, Bo Man Ho, Linbin Zhou, Yolanda Wong Ying Yip, Jing He, Yingying Wei, Clement C. Tham, Sun On Chan, Andrew V. Schally, Chi Pui Pang, Jian Li, Wai Kit Chu - Nature Communications 2023 cited by 34

  24. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction

    Authors: Raúl A Dulce, Rosemeire M. Kanashiro‐Takeuchi, Lauro M Takeuchi, Alessandro G. Salerno, Amarylis Wanschel, Shathiyah Kulandavelu, Wayne Balkan, Marilia Sanches Santos Rizzo Zuttion, Renzhi Cai, Andrew V. Schally, Joshua M. Hare - Cardiovascular Research 2022 cited by 28